Text: H.R.3537 — 114th Congress (2015-2016)All Information (Except Text)

Text available as:

Shown Here:
Referred in Senate (09/27/2016)


114th CONGRESS
2d Session
H. R. 3537


IN THE SENATE OF THE UNITED STATES

September 27, 2016

Received; read twice and referred to the Committee on the Judiciary


AN ACT

To amend the Controlled Substances Act to add certain synthetic substances to schedule I, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Dangerous Synthetic Drug Control Act of 2016”.

SEC. 2. Treatment of certain designer drugs as schedule I controlled substances.

(a) Cannabimimetic agents.—Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (d)(2)(B)—

(1) in clause (xiv) by striking “and” at the end;

(2) in clause (xv) by striking the period and inserting a semicolon; and

(3) by adding at the end the following:

“(xvi) 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (JWH–251);

“(xvii) (1-butyl-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone (4′-methyl JWH–073);

“(xviii) 2-(3-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (JWH–302);

“(xix) N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (5F–APICA);

“(xx) quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5F–PB–22);

“(xxi) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB–PINACA);

“(xxii) N-(naphthalen-1-yl)-1-pentyl-1H-indole-3-carboxamide (MN–24);

“(xxiii) (1-(5-fluoropentyl)-1H-indazol-3-yl)(naphthalen-1-yl)methanone (THJ–2201);

“(xxiv) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADBICA);

“(xxv) methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (5F–AMB); and

“(xxvi) methyl 2-(1-(cyclohexylmethyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (MA–CHMINACA).”.

(b) Synthetic opioids.—Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (a) by adding at the end the following:

“(43) Butyryl fentanyl.

“(44) beta-Hydroxythiofentanyl.

“(45) Acetyl fentanyl.”.

(c) Other drugs.—Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (c) by adding at the end the following:

“(29) 1-(naphthalen-1-yl)-2-(pyrrolidin-1-yl)pentan-1-one (α-naphyrone).

“(30) 1-(2,3-dihydrobenzofuran-5-yl)propan-2-amine (5–APDB).

“(31) 1-(2,3-dihydrobenzofuran-6-yl)propan-2-amine (6–APDB).

“(32) 6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine (MDAI).

“(33) 5-iodo-2,3-dihydro-1H-inden-2-amine (5–IAI).

“(34) 1-(4-bromofuro[2,3-f]benzofuran-8-yl)propan-2-amine (bromo-dragonfly).

“(35) 1-(4-chloro-2,5-dimethoxyphenyl)propan-2-amine (DOC).

“(36) 1-(4-ethoxy-2,5-dimethoxyphenyl)propan-2-amine (MEM).”.

Passed the House of Representatives September 26, 2016.

    Attest: karen l. haas,   
    Clerk.